Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
1.180
+0.025 (2.16%)
At close: Nov 13, 2026, 4:00 PM EST
1.170
-0.010 (-0.85%)
After-hours: Nov 13, 2026, 7:42 PM EST
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $15.74 million as of November 13, 2026. It is the 38,568th most valuable company in the world and the 5,289th biggest in the United States. Its market cap has decreased by 60.41% in one year.
Market Cap
15.74M
Enterprise Value
119.95K
1-Year Change
-60.41%
Global Rank
Country Rank
#5,289 United States
Category
ChartMarket Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $15.74M, a decrease of -90.78%. That is a compound annual growth rate of -77.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 15.74M | -60.98% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 15.69M |
| BioVie | 15.69M |
| aTyr Pharma | 15.52M |
| NewcelX | 15.48M |
| Acumen Pharmaceuticals | 15.16M |
| Marker Therapeutics | 15.12M |
| Allarity Therapeutics | 14.77M |
| Jasper Therapeutics | 14.53M |